The startup Swipcar, led by Julio Ribes (EMBA 16), presented at the 136th IESE Business Angels Network Investment Forum, and was invested in by a group of IESE alumni. Swipcar is a leading Spanish digital car subscription marketplace Based in Barcelona with growing presence in Italy and Portugal Offers a wide selection of cars for […]
Nine innovative European startups pitch to IESE’s Business Angel Investor Network
Nine innovative startups from four European countries presented their agritech projects to investors in IESE’s Business Angels Network as part of a continent-wide drive by the European Institute of Innovation & Technology (EIT) to promote new technologies in food production and processing. The Investment Forum was held October 27 at IESE’s Madrid campus. The startups […]
IESE’s Finaves and Business Angels Invest in Facility Management Platform Taclia
Finaves V, the seed capital fund promoted by IESE, and investors from IESE’s Business Angels Network have together invested in Taclia, a one-stop platform and software company for facility services such as repairs, heating and cooling systems, plumbing and grounds maintenance. In addition to Finaves and reinsurance company NacionalRe, member of the IESE Business Angels […]
Finaves in $6m Financing Round for U.S. Expansion of BusUp
IESE venture capital fund Finaves has taken part in a $6 million financing round for the U.S. expansion of BusUp, a Barcelona-based shuttle company that provides flexible corporate commuting services. BusUp said in a statement that the Series A financing round will allow it to expand operations in the U.S. and consolidate other existing markets […]
IESE’s Finaves Invests in Neurotech Startup InBrain
Finaves V, IESE’s venture capital fund, is part of a group of investors providing €900,000 in financing for InBrain Neuroelectronics, a startup that is developing graphene-based technologies to treat neurological disorders such as epilepsy and Parkinson’s with unprecedented precision. Finaves contributed €150,000 to the round, which was led by Sabadell-Asabys and Alta Life Sciences, two […]
